Literature DB >> 17096027

Adenoviral-mediated interferon alpha overcomes resistance to the interferon protein in various cancer types and has marked bystander effects.

X Zhang1, Z Yang, L Dong, A Papageorgiou, D J McConkey, W F Benedict.   

Abstract

We have previously shown that intravesical administration of adenovirus encoding human interferon alpha-2b (Ad-IFN) induced a marked regression of superficial human bladder tumors derived from cells that are resistant to over 1 million units/ml of IFNalpha protein in vitro. In addition, Ad-IFN appeared to produce strong bystander effects. In this study, we show that Ad-IFN causes marked inhibition of cell growth and apoptosis in cells of various tumor types, all of which are resistant to IFNalpha protein. In addition, strong perinuclear IFN staining was seen in all cell lines following Ad-IFN transfection and was never observed after exposure to the IFN protein. Ad-IFN induced proteolytic processing of caspases 3, 8 and 9, indicative of enzymatic activation. However, the caspase-8-selective inhibitor, IETDfmk, blocked apoptosis only in the cell lines that were sensitive to the IFNalpha protein and had minimal effect on Ad-IFN-induced caspase-3 or -9 processing and cell death, indicating that death receptor-independent mechanism(s) were involved in the cytotoxic effects observed for cancer cell lines resistant to the IFNalpha protein. Moreover, we document that a yet to be identified soluble factor(s) is responsible for causing the bystander effect observed following Ad-IFN treatment in IFN protein-resistant cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17096027     DOI: 10.1038/sj.cgt.7701011

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  10 in total

1.  Direct gene transfer of adenoviral-mediated interferon α into human bladder cancer cells but not the bystander factors produced induces endoplasmic reticulum stress-related cytotoxicity.

Authors:  X-Q Zhang; Z Yang; W F Benedict
Journal:  Cancer Gene Ther       Date:  2010-12-24       Impact factor: 5.987

Review 2.  The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside.

Authors:  Jonathan J Duplisea; Sharada Mokkapati; Devin Plote; Kimberly S Schluns; David J McConkey; Seppo Yla-Herttuala; Nigel R Parker; Colin P Dinney
Journal:  World J Urol       Date:  2018-11-11       Impact factor: 4.226

3.  Direct cytotoxicity produced by adenoviral-mediated interferon α gene transfer in interferon-resistant cancer cells involves ER stress and caspase 4 activation.

Authors:  Z Yang; X-Q Zhang; C N P Dinney; W F Benedict
Journal:  Cancer Gene Ther       Date:  2011-06-17       Impact factor: 5.987

Review 4.  Oncolytic viruses: adenoviruses.

Authors:  Julia Niemann; Florian Kühnel
Journal:  Virus Genes       Date:  2017-07-12       Impact factor: 2.198

5.  Autophagy is induced by adenoviral-mediated interferon alpha treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced.

Authors:  X-Q Zhang; K Dunner; W F Benedict
Journal:  Cancer Gene Ther       Date:  2010-05-21       Impact factor: 5.987

6.  Conditioned medium from Ad-IFN-alpha-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect.

Authors:  X Zhang; L Dong; E Chapman; W F Benedict
Journal:  Cancer Gene Ther       Date:  2008-07-11       Impact factor: 5.987

7.  Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer.

Authors:  Colin P N Dinney; Mark B Fisher; Neema Navai; Michael A O'Donnell; David Cutler; Alice Abraham; Sophia Young; Beth Hutchins; Maria Caceres; Narendra Kishnani; George Sode; Constance Cullen; Guangcheng Zhang; H Barton Grossman; Ashish M Kamat; Marshall Gonzales; Michael Kincaid; Nancy Ainslie; Daniel C Maneval; Matthew F Wszolek; William F Benedict
Journal:  J Urol       Date:  2013-03-15       Impact factor: 7.450

8.  Use of monitoring levels of soluble forms of cytokeratin 18 in the urine of patients with superficial bladder cancer following intravesical Ad-IFNα/Syn3 treatment in a phase l study.

Authors:  W F Benedict; M Fisher; X-Q Zhang; Z Yang; M F Munsell; C N P Dinney
Journal:  Cancer Gene Ther       Date:  2014-02-07       Impact factor: 5.987

9.  Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance.

Authors:  Jennifer L Green; Robin E Osterhout; Amy L Klova; Carsten Merkwirth; Scott R P McDonnell; Reza Beheshti Zavareh; Bryan C Fuchs; Adeela Kamal; Jørn S Jakobsen
Journal:  Mol Ther Oncolytics       Date:  2021-11-12       Impact factor: 7.200

10.  Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker.

Authors:  M B Fisher; X-Q Zhang; D J McConkey; W F Benedict
Journal:  Cancer Gene Ther       Date:  2009-02-06       Impact factor: 5.987

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.